Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Intranasal Drug Delivery Market to 2024 - Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug Delivery

      Research and Markets Logo

      News provided by

      Research and Markets

      Aug 13, 2019, 07:00 ET

      Share this article

      Share this article


      DUBLIN, Aug. 13, 2019 /PRNewswire/ -- The "Intranasal Drug Delivery - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

      Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for this market. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

      This report analyzes the US Market for Intranasal Drug Delivery in US$ Million by the following Therapeutic Areas:

      • Allergic Infections
      • Analgesics
      • Osteoporosis
      • Vaccinations

      The report profiles 64 companies including many key and niche players such as:

      • Aegis Therapeutics LLC (USA)
      • AptarGroup, Inc. (USA)
      • AstraZeneca Plc. (UK)
      • MedImmune, Inc. (USA)
      • Becton Dickinson and Company (USA)
      • GlaxoSmithKline Plc. (UK)
      • Johnson & Johnson Inc. (USA)
      • Marina Biotech, Inc. (USA)
      • Merck & Co., Inc. (USA)
      • Nemera (France)
      • Novartis AG (Switzerland)
      • OptiNose US Inc. (USA)
      • Pfizer, Inc. (USA)
      • Valeant Pharmaceuticals International, Inc. (Canada)

      Key Topics Covered:

      I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
      Study Reliability and Reporting Limitations
      Disclaimers
      Data Interpretation & Reporting Level
      Quantitative Techniques & Analytics
      Product Definition and Scope of Study

      II. A US MARKET REPORT

      1. INDUSTRY OVERVIEW
      A Prelude
      Intranasal Cavity: An Attractive Drug Delivery Route to Cross the Blood Brain Barrier
      Factors Inhibiting Nose-to-Brain Transportation of Drugs
      Drug's Physico-Chemical Properties
      Drug Dose, Concentration & Volume Administration
      Mucociliary Clearance
      Existence of Enzymatic Activity
      Animal Species: Variations in Nasal Mucosa
      Overcoming Barriers to Nose-to-Brain Delivery of Drugs
      Prodrug Technique
      Innovative Formulation
      Use of Enzyme Inhibitors & Absorption Enhancers
      Bioavailability: An Important Facet of Intranasal Drug Delivery
      Chemical Modification
      Transient Modification & Limited Enzymatic Activity
      Bioavailability of Large Molecules
      Bio-Adhesive Polymers: Useful in Increasing Drug Absorption
      Outlook
      Nasal Drug Delivery Devices & Equipment
      Preservative Free Systems (PFS)
      Traditional Vs. Advanced Intranasal Drug Formulation Types
      Type of Nasal Delivery Vehicles with Select Therapeutic Agents and Area of Application

      2. MARKET DRIVERS, TRENDS & ISSUES
      Burgeoning Geriatric Populace Spurs Growing Demand for Intranasal Drug Therapies
      Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era
      Pharmaceutical and Medical Device Companies Vying to Develop New Intranasal Therapeutics for Allergic Rhinitis Patients
      FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis S
      FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment
      FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis
      FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment
      Intranasal Corticosteroids
      A Potential Treatment for Debilitating Chronic Rhinosinusitis Disease
      Select Intranasal Corticosteroid Brands for Adult and Pediatric Usage
      Self-Administration of Drugs Brings Intranasal Drug Delivery into the Spotlight
      Innovation in Drug Delivery: A Talisman for Success
      Active Pharmaceutical Ingredients Used in Formulations for Nasal Drug Delivery with Related Indications
      Controlled Release Technology Is the Buzz Word
      Target-Specific Delivery Devices: Of Critical Value
      Safety and Cost: Primary Growth Drivers
      Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug Delivery
      Intranasal Therapeutics Delivery
      A High Potential Method for Treating CNS Diseases
      Intranasal Insulin Delivery Offers Strong Clinical Significance
      Inhaled Insulin Market Challenged by Low Acceptance Levels
      Intranasal Delivery of Anti-emetic Agent Metoclopramide Hydrochloride Validated by Study on Rodents
      Intranasal Delivery of Peptide-Based Pharmaceuticals
      Select Protein, Peptide & Non-Peptide Drugs Available as Nasal Spray Solutions in the Marketplace
      Tight Junction Biology: A Key Speed Breaker in Commercialization
      RNA Interference (RNAi): A Tool to Manipulate Tight Junctions
      Research Studies Authenticate Benefits of Bi-Directional Nasal Drug Delivery
      Growing Interest for Preservative-free Nasal Spray Formulations
      Multi-Dose Containers Developed to Offer Resistance against Microbial Contamination

      3. RECENT RESEARCH & DEVELOPMENT INITIATIVES
      OptiNose XHANCE
      Nose-to-Brain Drug Delivery
      OPN-300
      A Potential Alternative for Many Brain Disorders
      Orexin-A Replacement for Treating Nacrolepsy
      Advanced Nanoparticle Nasal Spray to Enable Drug Delivery to Brain
      OptiNose Develops Innovative Treatment Option for Sinusitis
      Intranasal Administration of ATX-LIPO for Brain Targeting
      A Promising Therapy for ADHD
      Noteworthy Registered and Published Clinical Trials on Intranasal Psychotropics
      Focused Ultrasound Leveraged to Enhance Intranasal Drug Delivery
      Evoke Pharma Develops EVK-001 Intranasal Metoclopramide Delivery System for Treating Gastroparesis
      Smart Polymers with Temperature, pH or Ionic Response in Nasal drug Delivery
      Chitosan Thermosensitive Biogels Evaluated for Intranasal Delivery of CNS Drugs
      Select Nasal Drug Absorption Enhancers and Related Mechanisms
      Dendrimers to Enhance Water-solubility of Antipsychotic Drugs for Intranasal Administration
      Naloxone Hydrochloride Nasal Sprays Provides a Powerful Alternative for Opioid Overdose Medications
      OptiNose ONZETRA Xsail (AVP-825)
      An Innovative Breath- Powered Intranasal Delivery System for Migraine Treatment
      Clinical Study Demonstrates Faster Antidepression Effects of Intranasal Ketamine
      Intranasal Aerosol Dose of PH94B Investigated for Treating Social Anxiety Disorder (SAD)

      4. TECHNOLOGY OVERVIEW
      Intranasal Drug Delivery: A Descriptive Exposition
      Nasal Physiology
      Challenges Involved In Formulating Nasal Drugs
      The Importance of Bioadhesion
      Overview of the Traditional Drug Administration Routes, Molecular Weight Capabilities, and Dosage Range
      Intranasal Drugs
      Prescription (Rx) and Over-the-Counter (OTC)
      Differences between Systemic Delivery and Local Effects
      Nasal Powders Vs. Sprays
      Nasal Drug Delivery Devices
      Types of Drug Delivery Devices
      Droppers
      Sprays
      Aerosol Containers/Inhalers
      Pumps
      Nasal Aspirators
      Intranasal Drug Delivery Vis--vis Other Delivery Techniques
      Limitations of Intranasal Drug Delivery
      Allergy
      Definition
      Symptoms
      Allergic Rhinitis
      Nasal Allergies

      5. NASAL DELIVERED DRUGS: AN OVERVIEW
      Nasal Drugs for Allergies
      Corticosteroid Nasal Sprays
      Flonase
      Patanase
      Beconase
      Other Nasal Corticosteroid Drugs
      Antihistamine Nasal Sprays
      Astelin Nasal Spray
      Otrivin Nasal Spray
      Livostin Nasal Spray
      Other Nasal Antihistamine Drugs
      Select Brands of Allergy Relievers
      Nasal Drugs for Postmenopausal Osteoporosis
      Calcitonin-Salmon Nasal Spray
      Miacalcin Nasal Spray
      Fortical Nasal Spray
      Intranasal Pain Management Drugs
      Stadol Nasal Spray
      Imitrex
      Migranal
      Zolmitriptan Nasal Spray
      Intranasal Analgesics for Treating Migraine
      Intranasal Vaccination
      Process of Intranasal Immunization
      "LAIV" Nasal Spray Flu Vaccine
      FluMist Vaccine from MedImmune
      Intranasal Drugs for Sexual Dysfunction
      Nasal Spray for Treating Vitamin B12 Deficiency
      Nasal Spray for Aiding Smoking Cessation

      6. PRODUCT DEVELOPMENTS, APPROVALS & INTRODUCTIONS
      FDA Approves OptiNose XHANCE Nasal Spray
      Splintek Launches Intra-Nasal Sleep Inhaler
      Allergan Receives Market Authorization for TrueTear
      St. Renatus Launches Kovanaze Nasal Spray
      Perrigo and West-Ward Pharmaceuticals Launch Generic Store Brand Flonase
      Nemera Launches Advancia Multi-Dose Nasal Spray System
      Adapt Pharma Launches Narcan Opioid Antagonist
      Apotex Unveils Generic Version of Nasonex
      McNeil Consumer Healthcare Rolls Out OTC RHINOCORT
      OptiNose Bags FDA Approval for ONZETRA Xsail
      Avanir's Onzetra Secures FDA Approval
      FDA Approves Lannett's Sumatriptan Nasal Spray
      Meda's Dymista Bags Health Canada's Approval
      Endo Pharmaceuticals Announces Availability of NATESTO
      AstraZenca Canada Unveils FluMist for Children
      Perrigo Receives US FDA Approval for Generic Version of Sun Pharma's Kenalog
      GSK Rolls Out OTC Version of Flonase Allergy Relief
      Upsher-Smith Publishes Data from USL261 Phase 1 Trials
      KemPharm Concludes KP201/APAP's Human Abuse Liability Program
      OptiNose Publishes Results of OPN 375's Phase III Trial
      NanoBio's Genital Herpes Vaccine Proven Effective
      Recro Pharma Releases Further Details of Dex-IN's Phase II Clinical Trial
      Evoke Announces Phase III Trials of EVK-001
      FDA Accepts Filing of TARSA's TBRIA
      FDA Accepts Review of Pfizer's ALO-02
      Breckenridge Bags FDA Approval for Azelastine HCl Nasal Solution
      ZOMIG Gets FDA Approval

      7. RECENT INDUSTRY ACTIVITY
      Opiant Pharmaceuticals to Pursue Development of Intranasal Nalmefene
      Egalet and OraPharma to Co-Promote SPRIX Nasal Spray
      Aegis Develops Hydromorphone Nasal Spray
      Emergent Biosolutions to Develop Intranasal Spray for Treatment of Cyanide Poisoning
      Aptar Pharma to Manufacture Child-Resistant Nasal Pumps in North America
      Therapix and Yissum Sign License for Cannabinoid Nasal Drug Delivery Technology
      Impel NeuroPharma and Camargo Pharmaceutical Services Sign Service Agreements
      Egalet Inks Deal With Septodont for SPRIX Promotion
      Lilly Acquires Intranasal Glucagon Rights
      UAE recalls Otrivin Nasal Spray Batches
      Eli Lily Acquires Rights for Innovent's Intranasal Glucagon
      AstraZenca Commences Shipment of FluMist

      8. FOCUS ON SELECT PLAYERS

      9. US MARKET ANALYTICS

      III. COMPETITIVE LANDSCAPE

      • Total Companies Profiled: 64 (including Divisions/Subsidiaries 81)
      • The United States (48)
      • Canada (4)
      • Japan (2)
      • Europe (17)
        • France (2)
        • Germany (4)
        • The United Kingdom (4)
        • Rest of Europe (7)
      • Asia-Pacific (Excluding Japan) (7)
      • Middle East (2)
      • Latin America (1)

      For more information about this report visit https://www.researchandmarkets.com/r/tsalky

      Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

      Media Contact:

      Laura Wood, Senior Manager
      [email protected]  

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.